A significant advance in cancer research is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer protector protein is frequently inactivated in many forms of cancer, causing https://bookmarkuse.com/story21750797/vhh-fragments-reactivate-the-p53-protein-new-promising-approach-for-cancer-management